Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.36 USD | -12.20% |
|
-14.83% | -58.77% |
06-14 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
06-14 | Sector Update: Health Care | MT |
Evolution of the average Target Price on Cabaletta Bio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cabaletta Bio, Inc.
HC Wainwright | |
Jefferies & Co. | |
Morgan Stanley | |
Cantor Fitzgerald | |
Stifel Nicolaus | |
Wells Fargo Securities | |
Citigroup | |
Guggenheim | |
Chardan Research | |
Mizuho Securities | |
Evercore ISI | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- CABA Stock
- Consensus Cabaletta Bio, Inc.